Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
about
Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settingsMinority variants of drug-resistant HIV.Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance.Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.Current practices in laboratory monitoring of HIV infection.The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.Improving Clinical Laboratory Efficiency: Introduction of Systems for the Diagnosis and Monitoring of HIV Infection.Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention InitiativeLopinavir plasma concentrations and virological outcome with lopinavir-ritonavir monotherapy in HIV-1-infected patientsN-Heterocyclic Carbene Capture by Cytochrome P450 3A4Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.
P2860
Q28478154-9577C4D3-28C7-4C58-B896-5728D26F2D57Q34047780-43BE08E4-B8F2-4B80-BD1D-2D6A8FC154ECQ34487510-F1F5E56D-0399-4BD5-8947-BBD7E81C7694Q34937254-4CDDD83C-DB9D-49EB-A2EF-3C71A014C2D4Q35356381-2EC25D13-2F09-4CA4-8251-99D1756F440DQ35770853-E8EF2EDA-C394-458D-85E7-51560A02EB3AQ35809718-FDB655F0-56A5-411C-AFE9-86E8D17D2473Q36481637-45E4404C-CD7A-4F06-A8B7-E9764A932808Q36543830-E622C411-5D14-4D81-BB70-7205F24937F9Q37036468-11BA5F65-448E-4A98-A35C-FE21C139ABF0Q37062535-2600A9C8-5CE1-419B-963C-FE7FA6B837E1Q37458296-94D9220E-528D-42AC-AAD2-3F65400E292BQ40163370-1853A577-658C-4E88-B912-8F33C10E243FQ41857055-450A09A6-E504-45B9-B069-1DF679013137
P2860
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiretroviral drug resistance ...... tional AIDS Society-USA panel.
@en
Antiretroviral drug resistance ...... tional AIDS Society-USA panel.
@nl
type
label
Antiretroviral drug resistance ...... tional AIDS Society-USA panel.
@en
Antiretroviral drug resistance ...... tional AIDS Society-USA panel.
@nl
prefLabel
Antiretroviral drug resistance ...... tional AIDS Society-USA panel.
@en
Antiretroviral drug resistance ...... tional AIDS Society-USA panel.
@nl
P2093
P50
P1476
Antiretroviral drug resistance ...... ational AIDS Society-USA panel
@en
P2093
Bonaventura Clotet
Daniel R Kuritzkes
Deenan Pillay
Donna M Jacobsen
Douglas D Richman
Françoise Brun-Vézinet
International AIDS Society-USA
John W Mellors
Jonathan M Schapiro
Martin S Hirsch
P304
P577
2008-08-01T00:00:00Z